Zachary Imam, PhD

Zachary Imam, PhD is a Scientist III at Nanotein Technologies, Inc., where he plays a key role in the company's research and development efforts.1 He joined Nanotein Technologies in 2021, bringing his expertise in biomedical engineering, biophysics, and lipid nanoparticles to the team.1

Background and Education

Dr. Imam earned his PhD in Biomedical Engineering from the University of Texas at Austin.1 During his doctoral studies, he worked under Jeanne Stachowiak, focusing on developing lipid nanoparticles for cancer therapies.1 This background has proven invaluable in his current role at Nanotein.

Professional Experience

Before joining Nanotein, Dr. Imam held a position as a biophysical post-doctoral appointee at Sandia National Laboratories.1 There, he worked with George Bachand, investigating the interactions between kinesin proteins and lipid vesicles to create lipid nanotube networks.1

Role at Nanotein Technologies

At Nanotein, Dr. Imam leverages his previous experience to work on the company's platform technology.1 Specifically, he is involved in developing a T cell activation and expansion reagent.1 His expertise in lipid nanoparticle development, protein biophysics, and rheological characterization has been instrumental in advancing Nanotein's projects.3

Skills and Expertise

Dr. Imam is described as an organized, energetic, and dedicated research scientist with over 10 years of experience in his field.2 He has a strong background in:

• Biomedical engineering
• Biophysics
• Lipid nanoparticle development
• Protein biophysics
• Rheological characterization

Professional Presence

Dr. Imam maintains an active professional presence, participating in scientific conferences and presenting research findings. For instance, he presented a poster at the ISCT (International Society for Cell & Gene Therapy) conference, showcasing Nanotein's work in T-cell science.4

Zachary Imam's expertise and contributions are helping to advance Nanotein Technologies' mission in developing innovative solutions in the field of cell therapy and bioengineering.